| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8651029 | American Heart Journal | 2018 | 8 Pages |
Abstract
The SMART-CHOICE trial aims to examine the non-inferiority of monotherapy with one of any available oral P2Y12 inhibitors versus conventional DAPT of an identical P2Y12 inhibitor plus aspirin in a broad spectrum of patients receiving representative current-generation DES.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Young Bin MD, PhD, Seok Kyu MD, Ju-Hyeon MD, PhD, Eul-Soon MD, Deok-Kyu MD, PhD, Byung Ryul MD, PhD, Jong-Young MD, PhD, Joo Myung MD, MPH, Taek Kyu MD, Jeong Hoon MD, PhD, Jin-Ho MD, PhD, Seung-Hyuck MD, PhD, Sang Hoon MD, PhD, Hyeon-Cheol MD, PhD,